Canadians deserve equitable access to psychedelic-assisted therapy

The Hill Times

November 22, 2023

Our CEO Ben Lightburn wrote an op-ed for The Hill Times explaining why Canadians deserve equitable access to psychedelic-assisted therapy.

read more News

Innovative trial will use psilocybin to target relapse in opioid addiction

Filament Health Announces Issuance Of Common Shares To Negev Capital Investments Limited Pursuant To Advisory Agreement

Filament Health Announces Second Quarter 2024 Financial Results And Operational Highlights